Endovascular Stent Grafts Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The Endovascular Stent Grafts Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Endovascular Stent Grafts Market?
There has been a significant expansion in the market size for endovascular stent grafts in recent years, beginning at $1.05 billion in 2024 and expecting to surge to $1.45 billion in 2025, reflecting a compound annual growth rate (CAGR) of 37.8%. The considerable growth experienced in the past can be linked to factors such as the increased occurrence of aortic aneurysms, a growing elderly population, enhanced healthcare expenditure in developed areas, an upsurge in the amount of ambulatory surgical centers, and a rising prevalence of chronic diseases.

The market size for endovascular stent grafts is anticipated to exhibit significant growth in the coming years, expected to climb to a value of $5.19 billion by 2029, with a compound annual growth rate (CAGR) of 37.6%. The prospective growth during this forecast period can be credited to a variety of factors including the ongoing transition towards less invasive procedures, an upward trend in vascular diseases like atherosclerosis and pulmonary embolism, accommodating reimbursement policies, an influx in the number of hospitals, and a rising incidence of diabetes even among younger demographics. Future trends within the same timeline encompass incorporating artificial intelligence, the creation of groundbreaking imaging technologies, the development of patient-specific or customizable stent grafts, the advent of next-gen tissue-engineered vascular grafts, and technological advancements.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20549

What Are the Different Endovascular Stent Grafts Market Segments?
The endovascular stent grafts market covered in this report is segmented -

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts
2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:
1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Are the Primary Drivers Shaping the Endovascular Stent Grafts Market?
The escalating occurrence of cardiovascular disorders is anticipated to drive the expansion of the endovascular stent graft market. Cardiovascular disease (CVD), including a range of illnesses affecting the heart or blood vessels, is on the rise due to a blend of lifestyle habits, medical conditions, genetic factors, and environmental influences. Endovascular stent grafts present an advantageous solution for the treatment of cardiovascular diseases, emphasizing minimally invasive procedures and enhanced patient results. The stent graft strengthens the fragile vessel wall, preventing rupture and thereby minimizing potentially fatal complications. For instance, data from the Australian Institute of Health and Welfare, a government-based agency in Australia, reported that certified deaths from coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Therefore, the spike in cardiovascular diseases is a driving factor for the endovascular stent graft market.

Which Companies Are Leading in the Endovascular Stent Grafts Market?
Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

What Are the Major Trends Shaping the Alcohol Based Disinfectants Market?
Leading corporations in the endovascular stent grafts sector are striving to create novel solutions such as thoracic aortic stent-graft with the objective of increasing accuracy and effectiveness in managing thoracic aortic aneurysms and dissections, boosting patient results, and overcoming intricate anatomical difficulties with incipient technology and design enhancement. A thoracic aortic stent graft is a distinctive healthcare apparatus utilized in endovascular surgeries for the treatment of conditions related to the thoracic aorta, which is the aorta's segment housed within the chest. This device offers a safe, effective, and convenient approach to managing thoracic aortic illnesses. As an example, in February 2024, Endovastec, a company originating from China specializing in medical devices, unveiled the Multi-Branch Thoracic Aortic Stent-Graft System, also known as Hector, and finished its pioneering clinical application in Switzerland. Hector system is a considerable leap in the technological advancement in endovascular stent graft, with its multi-branch design catering to complicated thoracic aortic illnesses by adjusting and preserving significant branches of the aorta, such as the arteries vital to organ supply.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

What Are the Top Revenue-Generating Geographies in the Endovascular Stent Grafts Market?
North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Endovascular Stent Grafts Market?
2. What is the CAGR expected in the Endovascular Stent Grafts Market?
3. What Are the Key Innovations Transforming the Endovascular Stent Grafts Industry?
4. Which Region Is Leading the Endovascular Stent Grafts Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the endovascular stent grafts market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.